Lumipulse® G SARS-CoV-2 Ag included in EU’s common list of COVID-19 laboratory based antigenic assays
Product news
With this inclusion the Lumipulse G SARS-CoV-2 Ag test is acknowledged as a good quality assay fulfilling all validation requirements on clinical performance as reported by independent validation studies showing an excellent sensitivity and specificity.
The full list is available on the website of the European Commission.
More information about the Lumipulse G SARS-CoV-2 Ag can be found here.